
U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisers meet next week, but their agenda suggests they’ll skip some expected topics — including a vote on Covid shots — while taking up a longtime target of anti-vaccine groups. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading.
Main Idea: Robert F. Kennedy Jr.’s new vaccine advisers are set to review thimerosal, a longtime anti-vaccine target, while skipping a planned vote on Covid shots.
Key Points:
Changes to CDC vaccine advisers could weaken trust and make vaccine rules more confusing, raising costs and risks for patients, parents, and insurers.
Some people may welcome extra review of vaccine ingredients and policies,.
Rate how each entity in this article affected the American people.
The vaccine advisory panel whose membership, agenda, and recommendations are the main subject.
U.S. Health Secretary whose vaccine adviser changes and agenda are central to the article.
Major medical organization reacting to the committee changes and vaccine recommendations.
The federal agency whose vaccine recommendations and leadership vacuum are central to the story.
Named president of the American Academy of Pediatrics, quoted as a key critic of the agenda.
Federal department involved in the vaccine committee process and comment request.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentReferenced as the agency whose vaccine approvals underpin the committee’s recommendations.
Named vaccine expert quoted on the likely effects of targeting thimerosal.
Mentioned as the president under whom Robert F. Kennedy Jr. serves, providing political context.
Broad group of organizations urging insurers to continue paying for Covid vaccines.